Results 161 to 170 of about 22,911 (183)
Some of the next articles are maybe not open access.

Meropenem-vaborbactam for the treatment of complicated urinary tract infections including acute pyelonephritis

Expert Opinion on Pharmacotherapy, 2018
Meropenem-vaborbactam is a new beta-lactam/beta-lactamase inhibitor combination that combines a carbapenem antibiotic with a first-in-class, boronic acid pharmacophore, serine beta-lactamase inhibitor which has potent inhibitory activity against class A carbapenemases, especially Klebsiella pneumoniae carbapenemases (KPC), in addition to other class A ...
Gary, Wu, Eunah, Cheon
openaire   +2 more sources

Meropenem – Vaborbactam

2022
Michelle C. Simpson, Eric G. Schaefer
openaire   +1 more source

Meropenem/vaborbactam

Reactions Weekly, 2020
openaire   +1 more source

Meropenem/vaborbactam cost effective in Italy

PharmacoEconomics & Outcomes News, 2021
openaire   +1 more source

Early Experience With Meropenem-Vaborbactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections

Clinical Infectious Diseases, 2020
Liang Chen   +2 more
exaly  

Home - About - Disclaimer - Privacy